Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 131, Issue 2, Pages 437-444
Publisher
Springer Nature
Online
2011-03-02
DOI
10.1007/s10549-011-1422-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Urban–rural differences in breast cancer incidence in Egypt (1999–2006)
- (2010) Subhojit Dey et al. BREAST
- Inflammatory Breast Cancer: The Disease, the Biology, the Treatment
- (2010) Fredika M. Robertson et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Human mammary tumor virus in inflammatory breast cancer
- (2010) Beatriz G.-T. Pogo et al. CANCER
- Inflammatory breast cancer in Tunisia
- (2010) Hamouda Boussen et al. CANCER
- Phase II Study to Evaluate the Efficacy and Safety of Neoadjuvant Lapatinib Plus Paclitaxel in Patients With Inflammatory Breast Cancer
- (2010) Hamouda Boussen et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
- (2010) Luca Gianni et al. LANCET
- Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients
- (2009) An-Chi Lo et al. BREAST
- High Proportion of Inflammatory Breast Cancer in the Population-Based Cancer Registry of Gharbiah, Egypt
- (2009) Amr S. Soliman et al. Breast Journal
- Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors
- (2009) Hugo Arias-Pulido et al. GYNECOLOGIC ONCOLOGY
- Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study
- (2009) Bella Kaufman et al. LANCET ONCOLOGY
- Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world
- (2009) Subhojit Dey et al. MEDICAL HYPOTHESES
- Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin
- (2008) Azza Ben Hamida et al. BMC CANCER
- Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy
- (2008) Stephen Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- The Medical Treatment of Inflammatory Breast Cancer
- (2008) Shaheenah Dawood et al. SEMINARS IN ONCOLOGY
- Defining the Clinical Diagnosis of Inflammatory Breast Cancer
- (2008) S. Eva Singletary et al. SEMINARS IN ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started